Brief: ANI Pharmaceuticals Q2 Adjusted EPS USD 1.02 Vs. IBES Estimate USD 0.95
06/08/2024 11:50
Aug 06 (Reuters) - ANI Pharmaceuticals Q2 revenue USD 138.04 million vs. IBES estimate USD 129.1 million. * Q2 operating expenses USD 132.9 million * outlook FY adjusted EPS USD 4.38-4.82 * outlook FY adjusted EBITDA USD 140-150 million
Recent news on ANI Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
ANI Pharmaceuticals Q1 revenue rises 21%, adjusted EPS beats estimates
Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma